Annual report pursuant to Section 13 and 15(d)

SETTLEMENT LIABILITY (Details Narrative)

v3.24.1
SETTLEMENT LIABILITY (Details Narrative) - REGENXBIO [Member] - USD ($)
$ in Millions
Nov. 12, 2021
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]      
Settlement liabilities, current $ 30.0    
Loss contingency settlement agreement terms (1) $20.0 million paid in November 2021 after execution of the Settlement Agreement, (2) $5.0 million on the first anniversary of the effective date of the Settlement Agreement (paid in November 2022), and (3) $5.0 million upon the earlier of (i) the third anniversary of the effective date of the Settlement Agreement or (ii) the closing of a Strategic Transaction, as defined in the Settlement Agreement    
Effective interest rate stated percentage   9.60% 9.60%
Due in November 2024 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Long term debt   $ 4.6 $ 4.2